Welcome to our dedicated page for BlackRock ESG Capital Allocation Term SEC filings (Ticker: ECAT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
BlackRock ESG Capital Allocation Trust (ECAT) balances current income with long-term appreciation through a concentrated, ESG-screened portfolio. That focus makes its SEC disclosures rich with details on leverage levels, monthly distributions and sector exposure—information every income investor wants fast.
Our platform decodes each document in minutes. Want to spot BlackRock ESG Capital Allocation Trust insider trading Form 4 transactions? We stream those Form 4 insider transactions in real-time and translate the legalese into clear buying and selling charts. Curious about dividend changes? The next BlackRock ESG Capital Allocation Trust 8-K material events explained section flags distribution announcements the moment they hit EDGAR.
Digging into performance is simpler, too. The annual report—formally the BlackRock ESG Capital Allocation Trust annual report 10-K simplified—is condensed by our AI so you can understand NAV drivers without wading through 200 pages. Each quarter, the BlackRock ESG Capital Allocation Trust quarterly earnings report 10-Q filing arrives with AI-powered summaries that highlight leverage ratios, expense trends and sector shifts.
- AI-curated highlights of every filing type, from proxy statement executive compensation notes to shelf registrations
- Side-by-side comparisons for BlackRock ESG Capital Allocation Trust earnings report filing analysis
- Natural-language answers to “understanding BlackRock ESG Capital Allocation Trust SEC documents with AI” or “how to read ECAT Form N-CSR”
No more manual page-skimming—Stock Titan’s expert engine explains BlackRock ESG Capital Allocation Trust SEC filings explained simply, helping professionals track risk factors, strategy updates and BlackRock ESG Capital Allocation Trust executive stock transactions Form 4 before the market reacts.
Saba Capital Management, L.P. reported insider transactions in BlackRock ESG Capital Allocation Term Trust (ECAT). The filing shows two open‑market sales: 5,524 shares sold on
Saba Capital Management, L.P. reported two insider sales of BlackRock ESG Capital Allocation Term Trust (ECAT) common stock. On 09/30/2025 the reporting person sold 1,063 shares at $16.44, leaving 27,800,724 shares beneficially owned indirectly. On 10/01/2025 they sold 18,130 shares at $16.55, leaving 27,782,594 shares beneficially owned indirectly. The filer is identified as a Director and a 10% owner. The form is signed by Saba Capital Management, L.P., Zachary Gindes and Boaz Weinstein.
Saba Capital Management, L.P. reported an insider transaction in BlackRock ESG Capital Allocation Term Trust (ECAT) on a Form 4. The filing shows a sale of 1,113 shares of common stock on 09/25/2025 at a price of $16.24 per share. After the sale, the reporting person(s) beneficially owned 27,801,787 shares indirectly. The Form 4 is signed by Zachary Gindes and Boaz Weinstein on 09/29/2025.
Saba Capital Management, L.P. reported insider dispositions of BlackRock ESG Capital Allocation Term Trust (ECAT). The filing shows two sales: 17,785 shares sold on 09/23/2025 at $16.45 and 28,886 shares sold on 09/24/2025 at $16.39. After the transactions the reporting person beneficially owned 27,802,900 shares on an indirect basis, indicating continued substantial indirect ownership following the disposals.
Saba Capital Management, L.P. reported a sale of 5,776 shares of BlackRock ESG Capital Allocation Term Trust (ECAT) on 09/16/2025 at $16.51 per share. After the transaction the filer reports beneficial ownership of 27,849,571 shares held indirectly. The Form 4 is signed by representatives Zachary Gindes and Boaz Weinstein on 09/17/2025, and the filing indicates the reporting person is a director and a 10% owner.
Saba Capital Management, L.P. reported sales of common stock in BlackRock ESG Capital Allocation Term Trust (ECAT). The filing shows two transactions: on 09/11/2025 Saba sold 4,006 shares at $16.76, and on 09/12/2025 it sold 19,682 shares at $16.79, totaling 23,688 shares sold. After the transactions, Saba held 27,855,347 shares beneficially. The ownership is reported as indirect, and the reporting relationship checked indicates Director and 10% owner status. No derivative securities were reported. The form is signed by Zachary Gindes and Boaz Weinstein on 09/15/2025.
Saba Capital Management, L.P. and individual reporting person Boaz Weinstein filed a Form 4 disclosing sales of common stock of BlackRock ESG Capital Allocation Term Trust (ECAT). On 09/09/2025 they reported a sale of 76,416 shares at $16.69 and on 09/10/2025 a sale of 109,895 shares at $16.70. Following those sales the reporting entities beneficially owned 27,988,930 and 27,879,035 shares, respectively. The form is signed and dated 09/11/2025.
Saba Capital Management, L.P. and reporting person Boaz Weinstein disclosed a sale of common stock of BlackRock ESG Capital Allocation Term Trust (ECAT). On 09/08/2025 they sold 79,152 shares at $16.66 per share. After the transaction they report beneficial ownership of 28,065,346 shares, held indirectly. The filing lists the reporters as a director and a 10% owner.
Form 4 shows Saba Capital Management and Boaz Weinstein reported sales of BlackRock ESG Capital Allocation Term Trust (ECAT) common stock. The filing lists two dispositions: 91,395 shares sold at $16.55 and 67,373 shares sold at $16.56, leaving an indirect beneficial ownership of 28,144,498 shares after the second sale. Both reporting persons are identified as directors and 10% owners.
Form 4 disclosure: Saba Capital Management, L.P. and Boaz Weinstein reported sales of BlackRock ESG Capital Allocation Term Trust (ECAT) common stock on 09/02/2025 and 09/03/2025. The filings show dispositions of 130,848 shares at $16.38 and 89,882 shares at $16.50, respectively. After these transactions, the reporting persons beneficially owned 28,303,266 shares (indirect).
FAQ
What is the current stock price of BlackRock ESG Capital Allocation Term (ECAT)?
What is the market cap of BlackRock ESG Capital Allocation Term (ECAT)?
